Pivotal Phase III study shows Roche’s Tecentriq helped people with early lung cancer live longer without their disease returning

NEXT STORY
Vaccitech Appoints Joseph Scheeren, PharmD, to its Board of Directors
PREV STORY
Meticore Reviews – Important News Reported by Researched Reviews
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences to Report Second Quarter 2017 Financial Results on Friday, August 11, 2017

WATERTOWN, Mass., Aug. 04, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage ...

author_avatar
NASDAQ Market News

MPI – LiPlaCis Phase 2 Recruitment Ongoing in DRP Screened Breast Cancer Patients: Relevant Clinical Benefits in 3 out of 5 Treated Patients

Hoersholm, Denmark, September 19, 2017 - Medical Prognosis Institute A/S ("MPI") today announced early ...

author_avatar
NASDAQ Market News

Integrated Benefits Institute Analysis Links Extreme Weather to Mental Health Disability Claims

Polar vortex and other severe weather events can disrupt business operations through disability leaves ...

author_avatar
NASDAQ Market News